Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Conditions
Recurrent Prostate Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Kantonsspital Baden, Baden, Switzerland
Contact: Principal Investigator (Andreas Erdmann, MD)Universitätsspital Basel, Basel, Switzerland
Contact: Principal Investigator (Cyrill A. Rentsch, Prof)EOC - Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
Contact: Principal Investigator (Thomas Zilli, Prof)Kantonsspital Graubünden, Chur, Switzerland
Contact: Principal Investigator (Angela Fischer, MD)Spital Thurgau AG, Frauenfeld, Switzerland
Contact: Principal Investigator (Jeanne Godau, MD)Hôpitaux Universitaires Genève HUG, Geneva, Switzerland
Contact: Principal Investigator (Petros Tsantoulis, MD)Luzerner Kantonsspital, Lucerne, Switzerland
Contact: Study coordinator (Christian Rothermundt, MD) · christian.rothermundt@luks.ch · +41 41 205 58 60Contact: Principal Investigator (Christian Rothermundt, MD)TBZO Tumor- und BrustZentrum Ostschweiz - Rapperswil, Rapperswil, Switzerland
Contact: Principal Investigator (Deborah Zihler, MD)HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen, Switzerland
Contact: Principal Investigator (Stefanie Fischer, MD)Kantonsspital Winterthur, Winterthur, Switzerland
Contact: Principal Investigator (Beat Förster, MD)Universitätsspital Zürich USZ, Zurich, Switzerland
Contact: Principal Investigator (Anja Lorch, Prof)
Study leads
Stefanie Fischer, PD MD
Study Chair
HOCH Health Ostschweiz
Richard Cathomas, Prof
Study Director
Cantonal Hospital Graubünden